Postnatal Changes in the Expression Pattern of the Imprinted Signalling Protein XLαs Underlie the Changing Phenotype of Deficient Mice by Krechowec, Stefan O. et al.
Postnatal Changes in the Expression Pattern of the
Imprinted Signalling Protein XLas Underlie the Changing
Phenotype of Deficient Mice
Stefan O. Krechowec
1., Katie L. Burton
1., Anna U. Newlaczyl
1, Nicolas Nunn
1, Nikolina Vlatkovic ´
2,
Antonius Plagge
1*
1Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom, 2Molecular and Clinical Cancer
Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
Abstract
The alternatively spliced trimeric G-protein subunit XLas, which is involved in cAMP signalling, is encoded by the Gnasxl
transcript of the imprinted Gnas locus. XLas deficient mice show neonatal feeding problems, leanness, inertia and a high
mortality rate. Mutants that survive to weaning age develop into healthy and fertile adults, which remain lean despite
elevated food intake. The adult metabolic phenotype can be attributed to increased energy expenditure, which appears to
be caused by elevated sympathetic nervous system activity. To better understand the changing phenotype of Gnasxl
deficient mice, we compared XLas expression in neonatal versus adult tissues, analysed its co-localisation with neural
markers and characterised changes in the nutrient-sensing mTOR1-S6K pathway in the hypothalamus. Using a newly
generated conditional Gnasxl lacZ gene trap line and immunohistochemistry we identified various types of muscle,
including smooth muscle cells of blood vessels, as the major peripheral sites of expression in neonates. Expression in all
muscle tissues was silenced in adults. While Gnasxl expression in the central nervous system was also developmentally
silenced in some midbrain nuclei, it was upregulated in the preoptic area, the medial amygdala, several hypothalamic nuclei
(e.g. arcuate, dorsomedial, lateral and paraventricular nuclei) and the nucleus of the solitary tract. Furthermore, expression
was detected in the ventral medulla as well as in motoneurons and a subset of sympathetic preganglionic neurons of the
spinal cord. In the arcuate nucleus of Gnasxl-deficient mice we found reduced activity of the nutrient sensing mTOR1-S6K
signalling pathway, which concurs with their metabolic status. The expression in these brain regions and the
hypermetabolic phenotype of adult Gnasxl-deficient mice imply an inhibitory function of XLas in energy expenditure
and sympathetic outflow. By contrast, the neonatal phenotype of mutant mice appears to be due to a transient role of XLas
in muscle tissues.
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Introduction
In mammals the paternally and maternally inherited genomes
contribute unequally to the development of offspring [1,2], which
can be attributed to epigenetic modifications that are established
in the two parental germlines. This process of ‘genomic
imprinting’ results in the differential silencing and parent-of-origin
specific, monoallelic expression of a subset of genes. [3–5] (for
imprintedgene databasessee:http://www.mousebook.org/catalog.
php?catalog=imprinting and http://igc.otago.ac.nz). Many im-
printed genes have been shown to influence embryonic growth, but
an increasing number are now being recognised for their roles in
postnatal development as well as having lasting effects on adult
physiology and/or behaviour [6–12]. A recurring theme for the
action of imprinted genes through embryonic and postnatal
development is the partitioning of nutrients and other resources
between mother and offspring [6,7]. Furthermore, those imprinted
genes that have been shown to exert a (continued) function at the
adult stage usually impact on energy homeostasis or behaviour
through their expression in metabolically relevant tissues and
defined regions of the centralnervoussystem (CNS) [6,9,12]. Many,
but not all, murine imprinted gene functions are conserved in
humans, and several human genetic disorders are associated with
imprinted gene loci, e.g. Beckwith-Wiedemann-Syndrome, Prader-
Willi-Syndrome/Angelman-Syndrome, Silver-Russell-Syndrome
and Transient Neonatal Diabetes Mellitus [13].
One of the first genomic regions that was recognised as being
imprinted is located on mouse distal chromosome 2 [14]. The
imprinted locus responsible for the observed abnormal phenotypes
was later identified as the Gnas locus, which is conserved on human
chromosome 20q13.32 and consists of a complex arrangement of
alternatively spliced transcripts and imprinted promoters that
cause parent-of-origin specific effects when mutated (Figure 1)
[15–20]. The two main protein-coding transcripts of the locus
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signalling protein Gas, and its variant Gnasxl, which translates into
XLas, an NH2-terminally extended version of Gas [21]. Gnas and
Gnasxl are derived from separate promoters, but share their open
reading frame from exon 2 onwards. Despite their different NH2-
termini, both proteins can stimulate adenylyl cyclase and cAMP
production upon activation of various receptors in transfected cells
[22]. However, the Gnas and Gnasxl transcripts differ with regard to
their regulation by genomic imprinting. In most cell types Gnas is
not imprinted, but in a subset of tissues its paternal allele is
silenced, resulting in a reduced dosage of Gas, e.g. in proximal
renal tubules, anterior pituitary, ovary, thyroid gland and the
paraventricular nucleus of the hypothalamus [23–27]. By contrast,
Gnasxl is imprinted in the opposite way, and its expression from the
paternal allele is limited to a few tissues [15,18,28–30]. This
pattern of transcriptional activity is determined by differential
DNA methylation at the main imprinting control region (ICR) at
Nespas (Nespas ICR) and a second differentially methylated region
at exon 1A upstream of Gnas, both of which acquire methylation in
the maternal germline and maintain it throughout development in
all somatic cells of the offspring (Figure 1) [17,31–33]. The
complexity of the locus is further increased by the expression of
non-coding RNAs and a third differentially methylated region
(termed Nesp), which exert epigenetic regulatory functions
(Figure 1) [17,34–36].
Gnas and Gnasxl differ not only in their imprinting, but also in
their tissue expression pattern and physiological functions [19,20].
In contrast to the almost ubiquitous expression of Gnas, little is
known about the tissue and cell type-specific expression of Gnasxl.
Limited data indicate an expression pattern mainly restricted to
neural, endocrine and some metabolically relevant peripheral
tissues, although these were not analysed in histological detail
[29,30,37]. Furthermore, the expression of Gnasxl in neonatal
adipose tissue and kidney appears to be silenced towards weaning
age, potentially indicating wider developmental changes in its
expression pattern [29,38,39]. The different and largely opposite
physiological functions of Gnas and Gnasxl have been characterised
in knock-out mice, in which the respective first exons were
disrupted, and in a mouse model carrying a missense point
mutation in exon 6 [23,25,30,39–42]. While homozygous
deficiency of Gnas is embryonically lethal, several tissue-specific
homozygous deletions have now been described [20]. However, it
is the heterozygous, maternally inherited mutation that displays a
distinct imprinting phenotype, due to the maternal allele-specific
expression of Gnas in some cell types [23,25,40–42]. These
phenotypes include neonatal subcutaneous oedema associated
with increased mortality and, in adulthood, resistance to several
hormones whose receptors signal via stimulation of cAMP
formation (e.g. parathyroid hormone in proximal renal tubules,
thyroid stimulating hormone in the thyroid gland) [25,40,41].
Mutation of Gnas on the maternal allele also causes severe obesity
with reduced energy expenditure and type 2 diabetes mellitus-like
symptoms (hyperglycemia, glucose intolerance, hyperinsulinemia
and insulin resistance) [20,41,42]. By analysing brain-specific,
maternally inherited Gnas deficiency Chen et al. showed that this
metabolic phenotype could be attributed to a homeostatic function
of Gas in the CNS [23]. A disruption of melanocortin 4 receptor
(MC4R) signalling, potentially in the paraventricular hypothalam-
ic nucleus where Gnas is imprinted, was implicated as the likely
cause for obesity and reduced energy expenditure. These murine
phenotypes largely reproduce the symptoms of a human genetic
disorder of maternally inherited GNAS mutations, termed ‘Alb-
right’s Hereditary Osteodystrophy / Pseudohypoparathyroidism
type Ia (AHO/PHP-Ia)’ [16,19].
In comparison, paternally inherited Gnasxl mutation causes in
many respects an opposite phenotype. At the neonatal stage,
Gnasxl is required for normal growth, feeding and activity, as
deficiency results in leanness, hypoglycemia, general hypotonia
and a high mortality rate [14,30,40]. This early neonatal
phenotype changes towards weaning age, and mutants that
Figure 1. Simplified scheme of the imprinted murine Gnas locus. The differential, parental allele-specific expression of the various transcripts
of the locus is indicated by arrows. Open and filled boxes represent non-coding and coding exons, respectively. Spliced transcripts and encoded
proteins are only shown for Gnas and Gnasxl above and below the parental alleles. On the paternal allele Gnas expression is silenced in specific tissues
(shaded Gnas exon 1 box). Gnasxl splices in frame onto exon 2 and encodes an ‘extra large’ a-subunit. Splicing onto exon N1 is limited to neural
tissue, results in premature termination of the open reading frame and expression of a truncated XLN1 protein. The alternatively spliced exon A20 is
found in a minority of Gnasxl transcripts, mainly in combination with exon N1, and introduces a frameshift and early termination codon in exon 2.
Nespas and exon 1A promoters generate non-coding regulatory RNAs. The Nesp transcript splices onto exon 2 and has a regulatory as well as protein
coding function. Regions of differential DNA methylation, including the imprinting control region (ICR) at Nespas, are symbolized by M.
doi:10.1371/journal.pone.0029753.g001
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fertile adults. However, adult Gnasxl-deficient mice retain a lean
and hypermetabolic phenotype throughout life despite increased
food intake, which contrasts with the obesity of maternal Gnas
mutants [39]. This leanness can be attributed to increased energy
expenditure, e.g. adipose tissue lipolysis, which is most likely due
to increased activity of the sympathetic nervous system (SNS) and
associated with increased glucose tolerance and insulin sensitivity
[39]. Apart from the Gnasxl knock-out [30], another mouse
model, which carries a missense point mutation in exon 6 (the
Oed-Sml mutation) [40,42,43], has been informative in the
assessment of phenotypes and how these relate to Gnasxl encoded
proteins. The exon 6 point mutation renders full-length XLas
(and Gas) non-functional, but does not affect the neural-tissue
specific truncated XLN1 protein (Figure 1). Neither does it affect
a potential third protein, Alex, which can be translated from a
highly unusual second, frame-shifted open reading frame that is
contained within the Gnasxl first exon [44]. The adult metabolic
phenotype of Sml mice was found to be largely identical to
Gnasxl
m+/p2 mice, which allowed the conclusion that full-length
XLas is the relevant protein involved in regulation of energy
homeostasis [42]. However, with regard to the neonatal feeding
phenotype differences were described between both mouse
models, which raises the possibility that the XLN1 or Alex
proteins have a role at this developmental stage [42]. On a
molecular level little is known about their potential functions,
since XLN1 lacks the signalling domains encoded by exons 4–12,
while Alex was described as a membrane associated protein that
interacts with XLas/XLN1 [44].
To gain insights into the causes of the developmentally
changing phenotype of Gnasxl-deficient mice, we systematically
analysed its expression pattern in the CNS and in peripheral
tissues at neonatal and adult stages. In this context we generated
an e w ,c o n d i t i o n a lGnasxl gene trap mouse model, which
expresses a XL-bGalactosidase fusion protein upon Cre recom-
bination, thus providing an excellent histological marker. We also
investigated co-localisation of XLas with neural peptides and
enzymes that are involved in the central regulation of energy
homeostasis. We identified several developmental changes in the
CNS expression pattern, and detected XLas in areas implicated
in the regulation of energy homeostasis and sympathetic outflow.
Histological analysis of the hypothalamic arcuate nucleus
revealed a reduced activity of the nutrient-sensing kinases
mTOR1-S6K, which concurs with the metabolic status and the
insulin sensitivity of Gnasxl knock-out mice. Surprisingly, in
peripheral tissues we determined several types of muscle,
including smooth muscle cells of blood vessels, as major sites of
expression at the neonatal stage. All muscle expression is silenced
in adulthood. The expression in blood vessels accounts for
previously obtained Gnasxl Northern blot signals from adipose
and other peripheral tissues.
Materials and Methods
Ethics Statement
All animal work was approved by the Ethical Review
Committee of the University of Liverpool and carried out in
accordance with MRC guidelines on ‘Responsibility in the use of
animals in bioscience research (May 2008)’ and under the
authority of the Home Office Project Licence PPL40/3009.
Mice
Mice (Mus musculus) carrying the general Gnasxl knock-out
mutation (Gnasxl
m+/p2 after paternal transmission) [30] were
maintained on the CD1 outbred genetic background (Charles
River, UK). The new conditional gene trap line XLlacZGT (strain
designation Gnasxl
tm2Pla, according to Targeted Mutation Nomen-
clature, Jackson Laboratory) was generated in the University of
Liverpool Transgenic Unit. Chimaeric XLlacZGT founder mice
were initially bred to Flpe-transgenic mice [45], to remove the frt-
flanked neo
r-cassette, and in the following generations XLlacZGT
females were paired to the CD1 strain background for mainte-
nance of the line and loss of the Flpe transgene. Its genetic
background is currently mixed 129 / C57BL/6J / CD1. Nestin-Cre
[46] and CMV-Cre [47] transgenic lines were maintained on
C57BL/6J strain background. All mice were kept under 12 hrs
light/dark cycle with ad libitum access to normal chow diet in air
conditioned facilities (20–22uC) of the Biomedical Services Unit of
the University of Liverpool.
ES cell culture and Gnasxl conditional gene trap
targeting
Mouse embryonic stem (ES) cell culture and G418 selection
were carried out as described previously [30], using a male ES cell
line (J1) [48], ES-cell certified medium and serum (Thermo
Scientific – HyClone), ESGROH (Millipore) and G418-resistant
primary embryonic fibroblasts as feeder cells. The conditional
gene trap vector contains the lacZ open reading and polyadenyl-
ation signals from pCMVb (Genbank ID: U02451, Clontech), to
which an 80 bp Gnas exon 2 splice acceptor sequence (position
190298–190377 bp of Genbank ID: AL593857) was added in
frame. The frt-flanked neomycin
r cassette was added from
pFRT2neolacZ [49]. LoxP and lox2272 sites [50] were assembled
by oligonucleotide annealing and cloned into the gene trap vector.
The sequence of this conditional gene trap plasmid pCLacZGT
has been submitted to Genbank ID: JN159854. For conditional
gene targeting 59- and 39-homologous arms of 5.8 kbp and
2.6 kbp, respectively, were added, resulting in the replacement
with targeting cassettes of a 958 bp sequence within intron 1 of
Gnasxl (position 156559–157516 bp in AL593857), which includes
the rarely spliced A20 exon. G418 resistant ES cell colonies were
screened by Southern blotting of SpeI – digested genomic DNA
with a 3.3 kbp AflII fragment external of the homologous arms.
One correctly targeted ES cell clone was identified and confirmed
in MfeI and AflII genomic DNA digests using neo
r and lacZ probes,
respectively, for Southern blotting. The targeted ES cell clone was
injected into C57BL/6J blastocysts, and male chimaeric founder
mice were bred to Flpe transgenic mice.
Histology
Tissues from adult mice were collected after perfusion under
terminal anaesthesia with 4% PFA/PBS and further fixed for
variable times appropriate for the type of histological staining
required. For cryostat sections cryo-protection was carried out in
30% sucrose/PBS. XGal staining for XL-bGalactosidase fusion
protein activity was carried out on whole-mount tissues or sections
as described [51]. Immunohistochemistry was carried out on
frozen sections using anti-XLas antibody (also recognises XLN1;
1:200 Santa Cruz, sc-18993) with Vectastain Elite Goat IgG kit
(Vector Laboratories) and DAB/Ni colour substrate. Double
staining of XLas and Melanin Concentrating Hormone (anti-
MCH, 1:500 Phoenix Pharmaceuticals, H-070-47) was performed
as above with post fixing in 4% PFA between XLas and MCH
staining (goat anti rabbit HRP 1:1000, Jackson ImmunoResearch).
Immunofluorescence was carried out on frozen sections. Primary
antibodies were used in the following dilutions: 1:200 for anti-
XLas and anti-pS6 (Cell Signalling Technology, #2211), anti-
Tyrosine Hydroxylase (TH) (1:500, Millipore, AB152), anti-
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smooth muscle Actin (1:500, Sigma, A2547), anti-von Willebrand
factor (1:500, Dako, A0082), anti-Choline-acetyltransferase
(ChAT) (1:100, Millipore, AB144P) and anti-bGalactosidase
(1:500, Abcam, ab9361 or 1:2000, Cappel/MP Biomedicals,
#55976). Secondary antibody dilutions were as follows: donkey-
anti-goat AF488 (1:1000, Invitrogen), donkey-anti-chicken Dy-
Light
TM 594 (1:1000, Jackson ImmunoResearch), donkey-anti-
rabbit AF594 (1:1000, Invitrogen) and DAPI (1:1000, Invitrogen).
Percentage co-localisation of Orexin, pS6 and TH with XLas was
assessed by evaluating a representative number of 18 serial coronal
brain sections (14 mm), covering the full anterior – posterior extent
of the brain region examined from two mice, on an epifluorescent
microscope (Zeiss Axioskop 40). pS6 cell number was assessed by
evaluating epifluorescent images from 18 serial arcuate nucleus
sections per mouse from six pairs of female wild type and
Gnasxl
m+/p2 littermates (age 12 weeks, fed normal chow diet). Co-
localisation in blood vessels was examined by confocal imaging
(Leica SP2). In situ hybridisation for Corticotropin releasing hormone
(CRH) and Gnasxl was carried out using Digoxigenin-labelled RNA
probes as previously described [30].
RNA isolation and qRT-PCR
Total RNA was isolated from tissues via homogenisation in
TrizolH (Invitrogen). After Trizol/CHCl3/Isoamylalcohol extrac-
tion a DNA degradation step on gDNA eliminator columns
(Qiagen) was included and then an equal volume of 70% EtOH
added to the aqueous phase, followed by RNA purification on
RNeasy mini columns (Qiagen) according to manufacturer’s
instructions. The quality of the RNA was assessed by agarose gel
electrophoresis, and the concentration determined by absorption
at OD260. Reverse transcription of 1.75 mg total RNA was carried
out using SuperScript IIIH reverse transcriptase (Invitrogen) and
random hexamer primers according to the manufacturer’s
protocol. For quantitative PCR (qPCR) all samples were reverse
transcribed in the same experiment. cDNAs were diluted and
qPCR carried out on a Bio-Rad iQ5 cycler using the iQ
TM
SYBRH Green Supermix (Bio-Rad). qPCR data were normalized
to the two housekeeping genes Gapdh and Trf and evaluated using
the DDCt method. PCR primer sequences are provided in Table
S1. Standard PCR was carried out using GoTaqH Hot Start
Polymerase (Promega).
Plasma Ghrelin analysis
Adult Gnasxl
m+/p2 females [30] and their wild-type littermates
(aged 5–11 months), which had been fed ad libitum with a normal
chow diet, were terminally anaesthetized and blood collected by
cardiac puncture into heparinised tubes. Samples from all mice
were collected during the same circadian time period, between 6–
8 hrs into the light phase. Proteinase inhibitor Pefabloc SC
(Roche) was added to a final concentration of 1 mg/ml and
samples were centrifuged for 15 min, 4uC, 3000 g. Plasma was
taken, HCl added to a final concentration of 0.05 M and samples
stored at 280uC. Ghrelin was measured using the rat/mouse
Ghrelin (active & total) ELISA kit (Linco Research) according to
manufacturer’s instructions.
Statistical Analyses
Active Ghrelin plasma data were analysed by non-parametric
Mann-Whitney U test; total Ghrelin data were analysed by
Students t-test. The number of pS6-positive cells was analysed by
non-parametric Wilcoxon’s matched-pairs signed-ranks test. The
statistics software package Minitab was used.
Results and Discussion
A conditional Gnasxl gene trap line provides a lineage
marker for expression analysis
To distinguish between functions of Gnasxl in development and
adulthood and to analyse its roles in different tissues, a
conditionally targeted mouse model is required. We employed a
gene trap strategy to generate a conditionally targeted allele of
Gnasxl, since a standard approach of flanking the single Gnasxl
specific 59-exon with loxP sites would most likely result in
disturbance of the Nespas ICR with consequences for the
expression of other transcripts of the locus (Figure 1) [33]. The
conditional gene trap approach made use of two non-compatible
lox site pairs (loxP and lox2272) and Cre recombinase mediated
inversion of head-to-head oriented recombination sites, which was
followed in this case by excision of intervening sequences and
stable activation of the gene trap cassette (Figure 2A) [52]. The
gene targeting construct comprised the splice acceptor sequence of
Gnas exon 2, fused in frame to a LacZ-pA cassette, which served to
trap splicing from Gnasxl exon 1 and resulted in the expression of
an XL domain – bGalactosidase fusion protein (XL-bGal) after
Cre recombination. The frt-flanked neo
r cassette can be removed
by Flp recombinase after ES cell selection [49]. As a location for
the gene trap cassette we chose the position of the rarely used A20
exon, which was previously identified in a minority of cDNAs [15].
We confirmed the infrequent inclusion of this exon in Gnasxl
cDNAs from mouse brain by RT-PCR (Figure 2D, E). Exon A20
containing splice variants were hardly detectable in full-length
Gnasxl transcripts, but made up a larger proportion of the neural-
specific, truncated XLN1 transcripts. Sequencing of the A20 splice
forms revealed an exon size of 95 bp, inclusion of which causes a
frameshift and premature termination codon in exon 2 of the
Gnasxl open reading frame, similar to the human gene (Figure 2F)
[15]. Such a truncation of the XLas protein disrupts its cAMP
signalling function, but might be of little relevance for the already
truncated XLN1 protein, for which no specific role has been
described so far [29]. Therefore, as no specific relevance could be
assigned to A20 exon-containing splice variants, we chose to
replace it with the gene trap cassettes (Figure 2A). Thus, the gene
trap construct removes the exon 2–12 encoded signalling domains
from XLas and also truncates the short XLN1 protein further, but
it does not affect the open reading frame of the Alex protein,
which is confined to the first exon of Gnasxl [44]. During gene
targeting one correctly recombined ES cell clone was identified
(Figure 2B), which produced several germline transmitting
chimaeras. However, transmission of the mutated, inactive gene
trap allele from chimaeras (paternal transmission) was associated
with an unexpectedly high rate of neonatal mortality among pups,
which was reminiscent of general Gnasxl
m+/p2 knock-out mice
[30]. Very few offspring survived in crosses to C57BL/6J;
however, survival was improved on a CD1 outbred genetic
background. Removal of the frt-flanked neo
r cassette through
crosses to Flpe mice (Figure 2C) [45] did not improve survival,
suggesting that Gnasxl transcription might have become downreg-
ulated by the placement of the gene trap cassette at the A20 exon
position. Analysis of Gnasxl transcript levels in neonatal brain by
qRT-PCR confirmed this hypothesis, indicating a 90% downreg-
ulation in paternal mutation carriers, irrespective of whether the
gene trap cassette was in its inactive or in its Cre-recombined,
active orientation (Figure 2C, Figure S1). Further investigations
are currently under way to determine the cause of the unexpected
downregulation in Gnasxl expression levels. Although this reduc-
tion of Gnasxl expression levels compromised phenotype analysis of
conditional, Cre-induced gene trap mutants, the activated gene
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29753Figure 2. Generation of a conditional gene trap mouse line for Gnasxl. (A) The targeting construct comprises the Gnas exon 2 splice acceptor
(Ex2SA) fused in frame to LacZ-pA, an frt-flanked neo
r cassette and pairs of loxP/lox2272 sites assembled in head-to-head orientation. The gene trap
cassette was inserted in the non-functional (antisense) orientation at the rarely used A20 exon position (see D–F). Cre recombination results in
inversion at compatible lox sites followed by excision between head-to-tail sites, which results in a stably integrated gene trap that attracts splicing
from Gnasxl exon 1. The resulting XL domain – b-Galactosidase (XL-bGal) fusion protein lacks XLas function, but retains b-Galactosidase activity.
Relative positions of probes and restriction sites used in Southern-blots are shown, as are PCR primers (arrows) used in genotyping. (B) Southern blots
showing a correctly targeted ES-cell clone (SpeI: WT=16.1 kbp, targeted=20.4 kbp; AflII: targeted=13.7 kbp; MfeI: targeted=8.8 kb). (C) Genotyping
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provided a highly useful and faithful marker for the histological
analysis of the Gnasxl expression pattern and its developmental
changes in central and peripheral tissues.
Developmental changes in the brain expression pattern
of Gnasxl correlate with phenotype changes of knock-out
mice
To analyse the functionality of the gene trap construct we
crossed male Gnasxl gene trap carriers (XLlacZGT) with Nestin-Cre
transgenic females [46] and assessed the expression of the XL-
bGal fusion protein by XGal staining of neonatal brain sections of
double positive offspring. Fusion protein activity was readily
detected in novel, as well as previously identified, mid- and
hindbrain regions (Figure 3A–H), thus confirming the correct
spacial transcriptional activity of the Gnasxl gene trap [30]. These
regions comprised the orofacial motor nuclei (hypoglossal (12N),
facial (7N) and motor trigeminal nuclei (5N)), the noradrenergic
locus coeruleus (LC) as well as the gigantocellular reticular area
(Gi) and the nucleus ambiguus (Amb) of the medulla (Figure 3A, B,
D, G, H). Additional novel sites of expression included the anterior
pons, i.e. the pedunculopontine tegmental nucleus (PTg) and the
subcoeruleus area, including the noradrenergic A7 nucleus
(Figure 3C, D). Gnasxl expression was also discovered in several
regions of the neonatal hypothalamus, including the dorsomedial
(DMH) and lateral areas (LH), the suprachiasmatic nucleus (SCh)
and preoptic area (Figure 3E–G). No XGal staining was observed
in control brain tissues (Figure S2A). Immunohistochemical
analysis using an XLas-specific antibody (which also recognises
the truncated neural variant XLN1) on wild-type brain sections
was consistent with the gene trap expression pattern and in situ
hybridisation data [30], as it showed expression in the 12N, Gi and
raphe obscurus (ROb) of the medulla as well as the LC and
laterodorsal tegmental nucleus (LDTg) of the pons (Figure 3I–K).
The LDTg and the PTg constitute major cholinergic centres of the
brain [53]. In the hypothalamus the paraventricular nucleus
(PVH) was identified as an XLas-positive area in addition to the
DMH and LH (Figure 3L, M). Neonatal PVH expression was
consequently confirmed in XGal stained coronal sections of gene
trap tissue (data not shown). The specificity of the XLas antibody
was confirmed using brain sections from Gnasxl
m+/p2 mice, which
did not result in any staining (Figure S2C, D). In the arcuate
nucleus (Arc) of the hypothalamus no protein was detected on
postnatal day 1, but Gnasxl transcripts were expressed by day 4
(Figure S3A).
This pattern of expression in defined subregions of the
brainstem and midbrain, which includes nuclei involved in the
control of the autonomous nervous system, is highly suggestive in
the context of the neonatal phenotype of Gnasxl-deficient mice
[30]. As the mouse brain continues to develop during the first
postnatal week, Gnasxl expression is found to be strongest in
brainstem nuclei that have to be functional soon after birth, e.g. in
the motor nuclei that innervate orofacial muscles (5N, 7N, 12N)
[54–56]. The impaired feeding of Gnasxl-deficient pups [14,30]
correlates with the expression in these nuclei and with a role of
cAMP signalling in orofacial motoneuron activity [55]. However,
the function of XLas in these neurons remains to be determined,
and additional causes for this phenotype cannot be excluded (see
below). Similarly, the expression of XLas in other brainstem nuclei
is likely to be relevant for the relative inactivity seen in Gnasxl-
deficient neonates as, for example, the LC, LDTg, PTg and Gi
influence arousal states, wakefulness and sleep through their
widespread projections within the brain [57–60]. Additionally, the
ROb is implicated in SNS and autonomic motor outflow [61], and
the Amb constitutes a major centre of vagal, parasympathetic
outflow to the heart [62], suggesting that XLas might impact on
heart rate in mice. By contrast, the hypothalamus and its neural
circuits are still under development during the first postnatal week
[63,64], which makes an essential neonatal function of XLasi n
this brain region less likely. However, it cannot be excluded that
XLas deficiency impacts on hypothalamic development and
results in lasting effects on adult energy homeostasis regulation,
as has been shown in the case of leptin deficiency [63].
As the phenotype of Gnasxl-deficient mice changes from an often
lethal failure-to-thrive in the first postnatal week to an overall
healthy, but hypermetabolic and lean, physiology in surviving
adults [30,39], we analysed whether this might be based on
changes in the expression pattern of the gene. To obtain an initial
overview, we undertook XGal staining of vibratome sections of
adult brain from mice carrying the Cre-activated gene trap. These
indicated some areas of continued expression of Gnasxl, e.g. in the
Amb, Gi, 12N, 7N and 5N of the medulla, the LC and SubC of
the pons and the DMH, LH and SCh of the hypothalamus
(Figure 4A–C). Although the three orofacial motor nuclei stained
for the XL-bGal fusion protein (Figure 4B, C), we were unable to
detect XLas protein in these areas in tissue sections from adult
wild-types by immunohistochemistry (Figure 4D), and only
obtained weak staining of a small number of neurons by in situ
hybridisation (data not shown). These results indicate low,
downregulated expression levels in the motor nuclei that, however,
still produce a blue XGal precipitate in overnight stained 500 mm
thick vibratome sections. A downregulation and change in
requirement for XLas in orofacial motor nuclei would concur
with the gain of normal feeding capabilities at weaning and
increased food intake of adult Gnasxl knock-out mice [39]. To
further investigate the adult food intake phenotype, we analysed
the plasma levels of the peptide hormone Ghrelin, which is
produced by the stomach and stimulates food intake via actions in
the hypothalamus and brainstem [65]. In line with the increased
food intake data, we found total and active (acylated) Ghrelin
levels to be elevated in adult Gnasxl
m+/p2 mice (total Ghrelin:
Gnasxl
m+/p2=7.5360.87 ng/ml, WT=3.1960.31 ng/ml,
p,0.0001; active Ghrelin: Gnasxl
m+/p2=443.86677.85 pg/ml;
WT=200.74627.82 pg/ml, p=0.003; means 6 SEM; n=13–
15; Figure S4). These data support the view that the food intake
promoting functions of Ghrelin are not impaired by lack of XLas.
Furthermore, it appears likely that the elevated Ghrelin and food
intake levels of Gnasxl-deficient mice constitute a compensatory
physiological mechanism to counterbalance their hypermetabolic
phenotype.
PCRs for deletion of the neo
r cassette via Flpe mice (left), and for Cre recombinase mediated inversion of the gene trap (right). The Flpe / Cre status of
the samples is given above the lanes. For primer locations see (A). (D) Scheme indicating splicing of the rarely used A20 exon in full-length Gnasxl and
neural-specific XLN1 transcripts. Arrows indicate primers used in (E). (E) RT-PCR from wild-type brain using a common Gnasxl exon 1 primer combined
with reverse primers in exon 5 (full-length Gnasxl) or exon N1 (XLN1). Exon A20-containing products (size increase: 95 bp) are indicated by asterisks
above the respective bands and are hardly detectable in full-length transcripts (XL lanes), but are more prominent in XLN1 transcripts (N1 lanes). (F)
Inclusion of the A20 exon results in a frame shift and termination codon in exon 2. The translated Gnasxl-A20 sequence from (E) is shown: Gnasxl exon
1 sequence (not highlighted), exon A20 sequence (highlighted black), exon 2 sequence (highlighted grey).
doi:10.1371/journal.pone.0029753.g002
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e29753Further histological analysis of XLas also identified novel,
adult-specific expression in the nucleus tractus solitarius (NTS)
(Figure 4D), a brainstem area involved in regulation of energy
homeostasis [66]. In the ventral medulla expression was found in
the raphe pallidus (RPa) (Figure 4E), which, like the ROb,
constitutes part of the sympathetic outflow chain, e.g. towards
adipose tissue [61,67,68]. The RPa already stained XLas-positive
at neonatal stages [30] (and data not shown). Another noticeable
change of Gnasxl expression was observed in the cholinergic
LDTg of the pons, which was silenced at the adult stage, while
the neighbouring noradrenergic LC retained expression
(Figure 4F). XLas expression in the four hypothalamic nuclei
(Arc, DMH, LH, PVH) appeared more widespread in adult as
compared to neonatal tissue (Figure 4G, H), and high levels of
expression were found in the SCh at both stages (Figure 4A, H
and 3F, Figure S3A). Adult-specific XLas staining was identified
in a medial part of the amygdala close to the optic tract
(Figure 4G). High levels of expression, which developed from
early postnatal stages onwards, were also apparent in the preoptic
area ventral and rostral of the anterior commissure (Figure 4A, I,
J). Immunohistochemistry identified several subregions of the bed
nucleus of the stria terminalis, the anterodorsal preoptic nucleus,
the A14 dopaminergic area and parts of the lateral septal nucleus
as XLas-positive (Figure 4I, J). As subregions of the preoptic area
have been implicated, among other functions, in the control of
body temperature and sleep / arousal states [69–71], it is notable
that XLas expression also correlates on this CNS level with areas
of autonomic and homeostatic control. Furthermore, to investi-
gate another part of the hierarchical organisation of autonomic
systems that might be relevant for the increased SNS activity of
XLas deficient mice [39] (and our own unpublished data), we
investigated whether expression occurs in the spinal cord, which
contains sympathetic preganglionic neurons (SPNs) [68,69]. We
detected expression of XLas in scattered neurons of the
intermediolateral region of the spinal cord as well as in
ventrolateral, motoneuron-containing areas at neonatal and adult
stages (Figure 5A–C). To further analyse whether XLas
expression occurs in SPNs, we determined its co-localisation
with Choline acetyltransferase (ChAT), which serves as a marker
for SPNs as well as ventral motoneurons. We found co-expression
of the XL-bGal fusion protein in a large proportion of cholinergic
motoneurons. In the intermediolateral layer the two proteins
were mostly located in separate populations, with few neurons
showing co-expression. This was the case for neonatal and adult
stages (Figure 5D–G). Our findings indicate that XLas is less
likely to exert a crucial SNS-related function directly in SPNs.
However, XLas-positive cells and neurites were often found in
the vicinity of SPNs, suggesting that they might have a regulatory
influence on the latter. A summary of the developmentally
changing CNS expression pattern of Gnasxl is presented in Table
S2.
One of the main findings of this expression analysis is the
association of XLas with brain regions involved in the regulation
of SNS outflow. Multisynaptic retrograde tracer experiments
have identified the hierarchical organisation of SNS control
centres, which include the SPNs of the intermediolateral spinal
cord, several regions of the medulla oblongata (RPa, ROb, Gi,
NTS), as well as specific midbrain and hypothalamic regions
(PVH, DMH, LH, Arc, PreOp) [61,68,69]. Recent work has
especially emphasised the roles of the preoptic area and the
DMH, both of which express XLas extensively, in controlling the
medullary raphe and SNS-mediated thermoregulation [70–72].
Furthermore, the melanocortin/MC4R neuropeptide signalling
system localises to several of these sympathetic control regions
and stimulates energy expenditure, brown adipose tissue (BAT)
thermogenesis, sympathetic nerve activity and heart rate [67,73–
76]. Since Gnasxl-deficient mice show elevated energy expendi-
ture, sympathetic outflow and cardiovascular parameters [39]
(and our own unpublished data), it appears likely that a
hyperactive melanocortin system could, at least partly, account
for the knock-out phenotype. This hypothesis is supported by the
finding that the MC4R signals via Gas in vivo, as was shown by a
brain-specific knock-out of the maternal Gnas allele, which
partially recapitulates the obese, hypometabolic, bradycardic
and melanocortin-resistant phenotype of the Mc4r knock-out
[23,77,78]. Therefore, the largely opposite energy homeostasis
phenotypes of the Gnas and Gnasxl knock-out mice suggest that
XLas might act to antagonise the melanocortin pathway and
suppress SNS outflow [23,39,41]. However, the in vivo mecha-
nisms of XLas function and receptor coupling remain to be
determined.
Co-expression analyses of XLas with hypothalamic
neuropeptides and reduced activity of the mTOR1–S6K
signalling pathway, which regulates insulin and leptin
sensitivity
Since hypothalamic neuron populations and signalling path-
ways that regulate food intake and energy expenditure have been
well characterised over recent years [65,79,80], we investigated
potential co-localisation of XLas with relevant neural markers. In
the DMH/LH two neuron populations, expressing Orexin and
MCH, have diverse effects on energy balance. Although both
stimulate food intake, Orexin also stimulates energy expenditure,
while MCH has the opposite effect [65,79,81]. We found XLast o
be expressed in a proportion of Orexin neurons (,23%), but no
co-localisation was detected in MCH neurons (Figure 6A, B). An
increased activity of the Orexin pathway in Gnasxl knock-out mice
could contribute to the elevated food intake and energy
expenditure observed [39,81]. In the PVH, XLas was detected
in peripheral areas, but was not expressed in the central
subdivisions, which contain CRH neurons, a neuropeptide that
stimulates SNS outflow and energy expenditure (Figure 6C, D)
[82]. Further studies, with a marker for catecholaminergic neurons
(TH), showed co-expression not only in the noradrenergic neurons
of the locus coeruleus and the subcoeruleus area of the pons (data
not shown), but also in the A12 dopaminergic neurons of the Arc
Figure 3. Expression of Gnasxl in neonatal brain (P1). (A–H) XGal staining of neonatal brain sections (A–F coronal sections; G, H sagittal
sections), indicating XL-bGal fusion protein activity in Nestin-Cre/+; +/XLlacZGT offspring. Images are shown in posterior to anterior order covering the
medulla oblongata (A, B), pons (C, D) and hypothalamus (E, F). Sagittal sections are located peripherally (G) and close to the midline (H). Red arrows
indicate expression in blood vessels (compare Figure 7A–G). (I–M) Immunohistochemistry for XLas on coronal sections of the medulla oblongata (I, J),
pons (K) and hypothalamus (L, M) of wild-type brain. 5N – motor trigeminal nucleus, 7N – facial nucleus, 12N – hypoglossal nucleus, A7 – A7
noradrenaline cells, Amb – ambiguus nucleus, Amy – medial amygdaloid nucleus, Arc – arcuate hypothalamic nucleus, DMH – dorsomedial
hypothalamic nucleus, Gi – gigantocellular reticular nucleus, LC – locus coeruleus, LDTg – laterodorsal tegmental nucleus, LH – lateral hypothalamic
area, PreOp – preoptic area, PTg – pedunculopontine reticular nucleus, PVH – paraventricular hypothalamic nucleus, ROb – raphe obscurus nucleus,
SCh – suprachiasmatic nucleus, SubC – subcoeruleus nucleus. Scale bars=500 mm or as indicated.
doi:10.1371/journal.pone.0029753.g003
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29753Figure 4. Expression of Gnasxl in the adult brain. (A–C) XGal staining of CMV-Cre/+; +/XLlacZGT sagittal brain vibratome section (thickness:
500 mm) indicating XL-bGal fusion protein activity in the hypothalamus (A) and medulla ((B) midsagittal, (C) parasagittal). Note the reduced
expression levels in the 7N compared to the neonatal stage (compare Figure 3G and [30]). (D–J) Immunohistochemistry for XLas on coronal wild-type
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regulate prolactin secretion from the pituitary gland [83]. By
contrast, no co-expression was found in the A13 dopaminergic
cells of the zona incerta (Figure S3Bi). Similarly, no XLas
expression was detectable in the dopaminergic neurons of the
ventral tegmental area and substantia nigra (data not shown).
Neurons of the hypothalamic Arc influence energy homeostasis
in response to circulating levels of the peptide hormones leptin
and insulin [65,79,80]. Furthermore, we have previously shown
that XLas-deficient mice are hypoglycemic, have significantly
lower plasma levels of both hormones and show peripheral
insulin sensitivity [39]. One of the intracellular regulators of
leptin and insulin receptor signalling is the mTOR1–S6K
pathway, which constitutes a key integrator of cellular nutrient
sensing and metabolism in peripheral tissues as well as the
hypothalamus. mTOR1-S6K are activated by various stimuli,
including signal transduction from insulin and leptin receptors via
IRS1–PI3K–Akt (Figure S5) [80,84]. In a negative feedback loop
mTOR1-S6K mediate phosphorylation of IRS1, thus desensitis-
ing and inhibiting the PI3K–Akt signalling branch of the insulin
and leptin receptors, which can lead to hormone resistance. It has
also been shown that metabolically relevant mTOR1-S6K
signalling specifically occurs in Arc NPY/Agrp and POMC
neurons [85]. To investigate potential differences in this pathway
in Arc neurons of XLas-deficient mice, we first analysed co-
localisation of XLas with pS6, a substrate and marker of S6K
activity, in wild-type tissue sections. Next, we assessed pS6 signals
(number of pS6 positive neurons) comparatively in the Arc of WT
versus Gnasxl
m+/p2 mice, to test whether the metabolic status of
the knock-out mice correlates with a reduced activity of mTOR1-
S6K. In WT mice under ad libitum chow fed conditions ,32% of
XLas-expressing Arc neurons showed a pS6 signal (Figure 6E).
Under the same standard feeding conditions the number of pS6
positive neurons in the Arc of Gnasxl
m+/p2 mice was significantly
lower than in WT littermates (reduced by 46%; n=6; p=0.036)
(Figure 6F–H). These data confirm our hypothesis of reduced
activity of the mTOR1-S6K kinase pathway in Arc neurons of
XLas deficient mice, which concurs with their metabolic status.
Insulin injection in Gnasxl
m+/p2 mice results in a stronger
activation of the IRS1-PI3K-Akt pathway in peripheral tissues
when compared to WT controls, indicating a generally increased
insulin sensitivity [39]. CNS sensitivity to insulin and/or leptin of
Gnasxl-deficient mice will be explored in future experiments. It is
interesting to note that S6K-deficient mice exhibit a similar
metabolic phenotype as adult Gnasxl
m+/p2 mice, including
reduced body weight and adiposity, and increased food intake,
lipolysis, energy expenditure and insulin sensitivity [39,86]. It
currently remains uncertain whether the reduced activity of the
mTOR1-S6K pathway is involved in causing the lean and
hypermetabolic Gnasxl
m+/p2 phenotype, or whether this is a
consequence of a metabolic condition that originates from other
factors.
Peripheral Gnasxl expression is mainly limited to muscle
tissues, including smooth muscle cells of blood vessels,
and is silenced at adult stages
Our previous data on Gnasxl expression in peripheral neonatal
tissues, which was limited to Northern blot analysis, indicated
expression in brown and white adipose tissue, heart, kidney and
gastrointestinal tissues [30]. To investigate these findings on a
histological level, we analysed expression of the XL-bGal fusion
protein in crosses of male XLlacZGT carriers to Nestin-Cre and
CMV-Cre females [46,47]. In Nestin-Cre/+; +/XLlacZGT mice, we
initially noticed in whole-mount XGal stainings of neonatal spine
preparations that not only neural tissue of the spinal cord stained
positive, but also surrounding intercostal muscle. A more detailed
analysis confirmed expression in intercostal muscle and addition-
ally revealed expression in blood vessels passing through the tissue
(Figure 7A). No staining was observed in control muscle samples
from wild-type or single transgenic Cre or gene trap littermates
(Figure S2B). Further examination of skeletal muscle of the hind
limbs also showed expression of the XL-bGal fusion protein in
muscle fibers and more strongly in blood vessels (Figure 7B). This
was confirmed in wild-type tissue sections using XLas immuno-
histochemistry (Figure S2E, F). Although the expression of the
Nestin-Cre transgene is widely regarded as nervous system-specific
[46], our results agree with a previous report, which detected Cre
activity outside the nervous system, e.g. in the somite – myotome
lineage during embryonic development [51]. Thus, the Cre
activity of this transgenic line does reflect the wider expression
pattern of the Nestin gene, which includes muscle precursors [87].
The finding of Gnasxl gene trap activity in blood vessels raised the
possibility that previously obtained Northern blot signals from
various other tissues might in fact be due to blood vessel
contamination. Histological examination of neonatal brown
adipose tissue and heart confirmed this hypothesis as XL-bGal
fusion protein activity was only detected in blood vessels and not,
for example, in mature adipocytes (Figure 7C–E). Similar blood
vessel staining was also found in neonatal white adipose tissue and
pancreas (data not shown). To determine the cell type within blood
vessels that expresses Gnasxl, we examined co-localisation of XL-
bGal with markers for smooth muscle and endothelial cells (a-
smooth muscle Actin and von Willebrand factor, respectively)
using confocal microscopy. XL-bGal expression was detected in
the smooth muscle cells, but not endothelial cells, of blood vessels
(Figure 7F, G). Similar to skeletal muscle, vascular smooth muscle
cells are partly derived from the embryonic mesoderm / somite
lineage [88] and, therefore, Gnasxl expression is likely to reflect the
common embryonic origin of these tissues. Following reports that
Gnasxl mRNA and protein are downregulated in adipose tissue and
kidney from mid-postnatal stages onwards [38,39], we examined
expression of the XL-bGal fusion protein in adult tissues. No
bGalactosidase activity could be detected in whole mount XGal
stainings of adult intercostal muscle preparations, which also
contained blood vessels (Figure 7H). Skeletal muscle preparations
brain sections in caudal (medulla) to rostral (preoptic area) order. Changes from the neonatal pattern include downregulation of expression in the
12N (D i), silencing in the LDTg of the pons (F), novel expression in the nucleus tractus solitarius (D) and medial amygdala (G), and more widespread
expression in several hypothalamic nuclei (G, H) and the preoptic area (I, J). Note that in (F) the darkly stained area indicates the neuronal cell bodies
of the LC, while the surrounding lighter stained area represents the dense network of neurites emerging from the LC. Higher magnification images of
the region show no XLas signals in the neurons of the LDTg. 5N – motor trigeminal nucleus, 7N – facial nucleus, 12N – hypoglossal nucleus, A14 –
A14 dopamine cells, ac – anterior commissure, ADP – anterodorsal preoptic nucleus, Amb – ambiguus nucleus, Amy – medial amygdaloid nucleus,
Arc – arcuate nucleus, BAC – bed nucleus of the anterior commissure, BSTM – bed nucleus of the stria terminalis (medial parts), DMH – dorsomedial
hypothalamic nucleus, Gi – gigantocellular reticular nucleus, LC – locus coeruleus, LDTg – laterodorsal tegmental nucleus, LH – lateral hypothalamic
area, LSV – lateral septal nucleus (ventral part), NTS – nucleus tractus solitarius, PreOp – preoptic area, PVH – paraventricular hypothalamic nucleus,
RPa – raphe pallidus, SCh – suprachiamatic nucleus, SubC – subcoeruleus nucleus.
doi:10.1371/journal.pone.0029753.g004
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PLoS ONE | www.plosone.org 10 January 2012 | Volume 7 | Issue 1 | e29753Figure 5. Spinal cord expression of Gnasxl. (A–C) Immunohistochemistry of neonatal (P1) thoracic spinal cords from Nestin-Cre/+; +/XLlacZGT
mice using an anti-bGalactosidase antibody (red, A and C), or from wild-type mice using an anti-XLas antibody (purple DAB/Ni staining, B). Transverse
(A, B) and sagittal (C) sections are shown. Gnasxl expression is detected in scattered neurons of the intermediolateral region as well as in the
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PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e29753from the hind leg were negative for XL-bGal activity, too (data not
shown). Another muscle tissue, the tongue, followed a similar
pattern, as strong expression was found at neonatal stages, while
expression was silenced in the adult tissue (Figure 7I, J). The
expression in neonatal tongue muscle was confirmed using XLas
immunohistochemistry on wild-type tissue sections (Figure S2G,
ventrolateral, motoneuron containing area. (D–G) Co-staining for XL-bGal fusion protein (red) and Choline acetyltransferase (ChAT; green) on sagittal
sections from neonatal (D, E) and adult (F, G) spinal cords. ChAT marks cholinergic sympathetic preganglionic neurons of the intermediolateral layer
as well as ventrolateral motoneurons. While XLas and ChAT are co-expressed in the majority of motoneurons, they are only occasionally co-localised
in neurons of the intermediolateral layer (white arrows in (E–G)). Epifluorescent (D, F, G) and confocal (E) images are shown. (G) Shows a magnification
of the area indicated in (F). Note the plasma membrane association of XL-bGal fusion protein, due to palmitoylation of the XL domain [97]. Neonatal
tissues in (D, E) were obtained from Nestin-Cre/+; +/XLlacZGT offspring, while adult samples in (F, G) were derived from CMV-Cre/+; +/XLlacZGT mice.
doi:10.1371/journal.pone.0029753.g005
Figure 6. XLas co-localisation with hypothalamic neuropeptides and assessment of arcuate nucleus mTOR1-S6K activity in
Gnasxl
m+/p2 mice. (A) A representative image of co-localisation of XLas (green) with Orexin A (red) in the DMH/LH is shown (i) and quantification of
co-localised cell body staining is provided on the right (ii). (B)X L as (purple) and MCH (brown) are expressed in separate neuron populations in the
DMH/LH. (C, D) Immunofluorescence staining for XLas (C) and in situ hybridisation for CRH (D) in neighbouring hypothalamic sections indicate
separate expression domains in peripheral and central subdivisions of the PVH, respectively. (E) Co-localisation of pS6, a substrate and marker of
mTOR1-S6K activity, in XLas-positive neurons of wild-type Arc tissue. A representative image (i) and quantification (ii) of a series of sections from two
mice (age 12 weeks) is shown. ,32% of XLas-positive neurons show pS6 signals under ad libitum normal chow fed conditions. (F–H) Reduced
number of pS6 positive neurons in the Arc of Gnasxl
m+/p2 mice (aged 12 weeks on normal chow diet). Representative images of pS6
immunofluorescence of wild-type (F) and Gnasxl
m+/p2 (G) Arc sections are shown, and a quantification is provided in (H), (n=6; p=0.036). See
materials and methods for details of the quantification method.
doi:10.1371/journal.pone.0029753.g006
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PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e29753H). Blood vessels of other adult tissues were also negative for XL-
bGal expression, e.g. in brain (compare Figure 3C, F, G, H with
Figure 4A–C) and adipose tissue (data not shown).
Additionally to the characterisation of these novel peripheral
expression sites, we also examined the pituitary and adrenal
glands, since they had previously been shown by in situ
hybridisation to express Gnasxl mRNA [30]. In line with the
earlier data the neonatal pituitary stained positive for XL-bGal
activity in the intermediate lobe, which further confirms the
correct functionality of the conditional gene trap cassette
(Figure 7K; control in Figure S2I). However, in contrast to muscle
tissue, Gnasxl expression remained in the adult pituitary (Figure 7L)
[29]. The melanotroph cells of the intermediate lobe produce the
Pomc gene-derived peptide aMSH, but little is known about their
physiological function. Another neuroendocrine tissue, the adrenal
medulla, also showed XL-bGal fusion protein activity at neonatal
and adult stages (Figure S6). As part of the sympathetic stress
response the adrenal medulla secretes mainly epinephrine, which
has been shown to be elevated in Gnasxl
m+/p2 mice [39] and might
contribute to their hypermetabolic phenotype. The histological
analysis of Gnasxl expression in kidney and gastrointestinal tissues
[30] was complicated by endogenous bGalactosidase-like enzyme
activity in control samples (Figure S2J).
In summary, we have now associated the characteristic
phenotypes of neonatal and adult Gnasxl-deficient mice [30,39]
with the changing expression pattern of the gene. One
characteristic feature of mutant pups is their reduced suckling
activity, which was previously attributed to a potential role of
XLas in orofacial motor nuclei [30]. Our data now show that the
neonatal expression of XLas in these motor nuclei is downregu-
lated, but not completely silenced, at adult stages. In correlation
with this change in expression, food intake is no longer impaired in
adult Gnasxl
m+/p2 mice [39]. However, the newly identified,
transient high levels of XLas expression in neonatal muscle tissues,
especially tongue muscle, raise the possibility that the feeding
difficulties of mutants might be caused by a dysfunction of this
muscle tissue itself. XLas might also have a role in skeletal muscle
at the neonatal stage, which could explain the relative inactivity
and inertia observed in deficient pups [14,30]. Muscle-specific
disruption of Gnasxl, using a modified version of this gene trap line
(currently in progress), will be required to validate this hypothesis.
Such an experiment would also clarify whether the truncated
neural-specific XLN1 protein (Figure 1) has a role in neonatal
feeding, as has been suggested by Kelly et al. [42]. Mice with a
paternally inherited exon 6 mutation (Sml), which disrupts full-
length XLas but not XLN1, showed normal suckling activity.
Comparing their findings to Gnasxl
m+/p2 mice, in which all three
proteins (XLas, XLN1 and Alex) are deleted, the authors conclude
that XLN1 might have a role in neonatal feeding [30,42].
Although such a function of XLN1 cannot be excluded at this
stage, other factors can also contribute to differences in feeding
efficiency of Sml and Gnasxl
m+/p2 pups. It is well documented that
differences in genetic background, on which the two strains are
kept, influence postnatal survival; neither Oed-Sml nor Gnasxl
m+/p2
are viable on some strain backgrounds [30,42]. Overall, Sml and
Gnasxl
m+/p2 pups show very similar postnatal body weight
trajectories [30,40].
Since the expression of XLas in peripheral tissues is widely
silenced towards adulthood, it is highly likely that the lean and
hypermetabolic phenotype of Gnasxl
m+/p2 mice is due to a lack of
function in the CNS. Overall, the adult CNS pattern of XLas
expression correlates remarkably well with the hierarchical
organisation and control of sympathetic outflow on several levels,
including the preoptic area, Arc, DMH/LH, PVH, medullary
raphe, NTS and spinal cord [61,69,72,75,76]. Our finding that
XLas is located in a neuron population of the intermediolateral
spinal cord that is mostly different from, but often in the vicinity
of, the cholinergic SPNs suggests that it might play a role in a
pathway parallel to the SNS, i.e. in neurons that exert an
inhibitory influence on SNS outflow. Such an antagonistic
influence on the SNS could occur on the level of the spinal cord
as well as the medulla or hypothalamus. Little is known about
pathways that utilise cAMP stimulating receptors to antagonise or
inhibit metabolic rate and SNS outflow, i.e. pathways in which
XLas could act directly. By contrast, several stimulatory G-
protein coupled receptors are known to increase energy
expenditure and SNS functions, for example the melanocortin
receptor MC4R and the Glucagon-like peptide 1 receptor (GLP-
1R) [74,77,89].
The regulation of postnatal growth and adult energy
homeostasis has emerged as a common theme, on which, apart
from the Gnas locus with its two major protein products Gas and
XLas, a number of imprinted genes exert influence [6,9]. In fact,
it was recently shown that the imprinted adaptor protein Grb10 is
a direct target of mTOR1 and inhibits insulin / insulin-like
growth factor receptor signalling [90,91]. Accordingly, mice
lacking Grb10 expression from the maternal allele show a
phenotype that is characterised by overgrowth and increased
insulin sensitivity [92]. Furthermore, like Gnasxl, several imprint-
ed genes have roles in the CNS [10,12]. The Prader-Willi and
Angelman Syndrome (PWS-AS) locus, for example, contains a
cluster of imprinted genes with neural functions. Magel 2 and
Necdin are involved in the central stimulation of neonatal suckling
and respiration, respectively [93,94]. In adult mice Magel 2 affects
Orexin expression and feeding behaviour and additionally
regulates circadian rhythmicity in the suprachiasmatic nucleus
[11], which also expresses high levels of Gnasxl.T h em a t e r n a l l y
expressed Angelman Syndrome protein Ube3A, on the other
hand, is required for synapse formation and synaptic plasticity
[95]. These findings and the recent discovery of a large number
of monoallelically expressed transcripts in the brain [96]
demonstrate that the CNS constitutes an important tissue,
through which imprinted genes influence postnatal development
and adult homeostatic functions.
Figure 7. Expression of Gnasxl in peripheral tissues of Cre/+; +/XLlacZGT mice. Either the Nestin-Cre (A, B) or the CMV-Cre (C–L) transgenic line
was used to activate the gene trap cassette. (A) XGal whole-mount staining of neonatal (P1) intercostal muscle and blood vessels. (B) XGal, eosin
counter-stained section of P1 skeletal muscle from hind limb showing expression of the XL-bGal fusion protein in muscle fibres and blood vessels
(inset without eosin counter-staining depicts muscle fibre staining for clarity). (C, D) Blood vessel XGal staining in neonatal brown adipose tissue with
(C) and without (D) eosin counter-stain. (E) XL-bGal fusion protein activity in blood vessels of the heart, P1. (F, G) Gnasxl is expressed in smooth
muscle cells, but not endothelial cells, of blood vessels. Confocal imaging of neonatal blood vessels using antibodies for bGalactosidase and either a-
smooth muscle Actin (F) or von Willebrand factor (G). (H) Expression of XL-bGal fusion protein in intercostal muscle and blood vessels is silenced at
the adult stage. XGal staining of adult whole-mount tissue in comparison to (A). (I, J) XL-bGal expression in neonatal tongue muscle (I) is also silenced
at the adult stage (J); XGal whole-mount staining of longitudinally sectioned tissue samples. (K, L) Expression of Gnasxl in the intermediate lobe of
the neonatal pituitary (K) is maintained at the adult stage (L). XGal staining of whole-mount tissues. BV=blood vessel, IM=intercostal muscle. For
controls see Figure S2.
doi:10.1371/journal.pone.0029753.g007
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Figure S1 Analysis of Gnasxl transcript levels by qRT-
PCR. RNA from neonatal brain of wild-type, Cre/+; +/XLlacZGT
(inverted, active gene trap) and +/+; +/XLlacZGT (inactive gene
trap) littermates was analysed using primers specific for Gnasxl
exon 1. Expression levels were normalised to the housekeeping
genes Gapdh and Trf (n=4–5 per genotype).
(PDF)
Figure S2 Control stainings of tissues. (A) No blue colour
precipitate was visible in neonatal brain from wild-type or single
transgenic Cre/+; +/+ or +/+; +/XLlacZGT mice. Shown is a
XGal preparation of a wild-type whole-mount brain, cut sagittally
along the midline before incubation in staining solution. (B) XGal
preparation of a neonatal thoracic spine / intercostal muscle tissue
sample of a +/+; +/XLlacZGT mouse. (C), (D) Immunohisto-
chemistry of coronal sections of adult brain from wild-type (C) and
Gnasxl-deficient (Gnasxl
m+/p2) (D) mice using the anti-XLas
antibody. The hypothalamus and amygdala are shown. Both
sections were stained in the same experiment; lack of DAB/Ni
precipitate in the Gnasxl knock-out sample (D) confirms the
specificity of the antibody. (E), (F) Immunohistochemistry for
XLas on neonatal (P2) skeletal muscle sections from wild-type (E)
and Gnasxl
m+/p2 mice (F). The comparatively low affinity/avidity
of the XLas antibody is sufficient for detection of expression in
blood vessel, but did not produce a signal in skeletal muscle cells.
This is in line with the relatively higher expression levels of Gnasxl
in blood vessels as compared to skeletal muscle cells, which was
evident from XGal stained sections of gene trap tissue (see Fig. 7B).
(G), (H) Immunohistochemistry for XLas on neonatal (P2) tongue
muscle sections from wild-type (G) and Gnasxl
m+/p2 mice (H)
confirms faithful reporter gene expression after gene trap
activation (see Fig. 7I). (I) Neonatal (P1) wild-type pituitary
whole-mount XGal control staining. (J) Kidney from an adult +/+;
+/XLlacZGT control mouse (inactive gene trap) shows background
b-Galactosidase like activity. The tissue was cut longitudinally
before incubation in XGal solution. Amy – amygdala, PVH –
paraventricular hypothalamic nucleus, BV – blood vessel.
(PDF)
Figure S3 Expression and co-localisation of Gnasxl in
the hypothalamus. (A) Expression of Gnasxl in the hypotha-
lamic arcuate nucleus at postnatal day 4. An in situ hybridisation of
a sagittal brain section with a Digoxigenin-labelled RNA probe is
shown. (B)X L as expression in A12 dopaminergic neurons of the
arcuate nucleus of adult mice. (B i) Overview; XLas in green;
Tyrosine hydroxylase (TH) in red. White arrow=A12 dopamine
neuron group of the arcuate nucleus. Red arrow=A13 dopami-
nergic cells of the zona incerta (no co-localisation). (B ii) Higher
magnification showing co-localisation in a portion of arcuate
neurons. (B iii) ,65% of TH positive neurons in the A12
dopaminergic cell group showed XLas expression (n=2).
(PDF)
Figure S4 Plasma Ghrelin levels of Gnasxl
m+/p2 mice
are elevated. Plasma Ghrelin levels (active Ghrelin and total
Ghrelin) of Gnasxl-deficient (Plagge et al., 2004) adult females
(n=13) and their wild-type littermates (n=15) under ad libitum fed
normal chow diet conditions. Means 6 SEM; ** p=0.003 (active
Ghrelin) and p,0.0001 (total Ghrelin) versus WT.
(PDF)
Figure S5 Simplified scheme of the mTOR1-S6K nutri-
ent sensing kinase pathway in the context of InsR and
LepR signalling. Both receptors can activate mTOR1-S6K via
their IRS-PI3K-Akt signalling branch. Additional intracellular
nutrient sensing mechanisms further influence mTOR1-S6K
activity (not shown). In a negative feedback loop p70S6K1
phosphorylates and inhibits IRS1. Receptors are shaded as grey
boxes, kinases as brown boxes. Phosphorylation of the S6K1
substrate S6 serves as a histological marker for its activity.
(modified from Polak, P. and Hall, M. N., Curr. Op. Cell Biol. 21:
209–218 (2009); and Howell, J. J. and Manning, B. D., Trends
Endocrinol. Metab., 22: 94–102 (2011)).
(PDF)
Figure S6 XGal staining of (A) neonatal and (B) adult
adrenal glands of CMV-Cre/+; +/XLlacZGT mice. Tissues
were cut transverse and stained as whole-mounts over night. Blue
colour precipitate formed specifically in the adrenal medulla.
(PDF)
Table S1 Sequences of oligonucleotides used for geno-
typing, RT-PCR and qRT-PCR in Figure 2 and Figure S1.
(PDF)
Table S2 Summary of developmental changes in the
brain expression pattern of Gnasxl. Data are collated from
XLas/XLN1 immunohistochemistry, XLlacZGT gene trap fusion
protein expression and in situ hybridisation studies in this
manuscript and from Plagge A., et al., Nat. Genet. 36: 818–826
(2004). For abbreviations see main text and figure legends.
(PDF)
Acknowledgments
We would like to thank staff of the Biomedical Services Unit of the
University of Liverpool for expert animal care and support. Furthermore,
we are grateful to Dr. Bettina Wilm and Dr. John Quayle (University of
Liverpool) for antibodies, Dr. Wendy Dean and Dr. Martin Turner (The
Babraham Institute, Cambridge, UK) for CMV-Cre and Flpe transgenic
mice, and Dr. Axel Behrens, (Cancer Research UK, London) for the Nestin-
Cre transgenic line. We would also like to thank Dr. Gavin Kelsey (The
Babraham Institute, Cambridge, UK) for comments on the manuscript.
Author Contributions
Conceived and designed the experiments: AP SK KB. Performed the
experiments: SK KB AN NN NV. Analyzed the data: SK KB AN AP.
Contributed reagents/materials/analysis tools: NV. Wrote the paper: AP
SK KB.
References
1. McGrath J, Solter D (1984) Completion of mouse embryogenesis requires both
the maternal and paternal genomes. Cell 37: 179–183.
2. Surani MA, Barton SC, NorrisML (1984) Development of reconstituted mouse eggs
suggests imprinting of the genome during gametogenesis. Nature 308: 548–550.
3. Bartolomei MS (2009) Genomic imprinting: employing and avoiding epigenetic
processes. Genes Dev 23: 2124–2133.
4. Edwards CA, Ferguson-Smith AC (2007) Mechanisms regulating imprinted
genes in clusters. Curr Opin Cell Biol 19: 281–289.
5. Reik W, Walter J (2001) Genomic imprinting: parental influence on the genome.
Nat Rev Genet 2: 21–32.
6. Charalambous M, da Rocha ST, Ferguson-Smith AC (2007) Genomic
imprinting, growth control and the allocation of nutritional resources:
consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes 14: 3–12.
7. Constancia M, Kelsey G, ReikW (2004) Resourceful imprinting.Nature432: 53–57.
8. Curley JP, Pinnock SB, Dickson SL, Thresher R, Miyoshi N, et al. (2005)
Increased body fat in mice with a targeted mutation of the paternally expressed
imprinted gene Peg3. FASEB J 19: 1302–1304.
9. Frontera M, Dickins B, Plagge A, Kelsey G (2008) Imprinted genes, postnatal
adaptations and enduring effects on energy homeostasis. Ad Exp Med Biol 626:
41–61.
Postnatal Changes in XLas Expression Pattern
PLoS ONE | www.plosone.org 15 January 2012 | Volume 7 | Issue 1 | e2975310. Garfield AS, Cowley M, Smith FM, Moorwood K, Stewart-Cox JE, et al. (2011)
Distinct physiological and behavioural functions for parental alleles of imprinted
Grb10. Nature 469: 534–538.
11. Kozlov SV, Bogenpohl JW, Howell MP, Wevrick R, Panda S, et al. (2007) The
imprinted gene Magel2 regulates normal circadian output. Nat Genet 39:
1266–1272.
12. Wilkinson LS, Davies W, Isles AR (2007) Genomic imprinting effects on brain
development and function. Nat Rev Neurosci 8: 832–843.
13. Morison IM, Ramsay JP, Spencer HG (2005) A census of mammalian
imprinting. Trends Genet 21: 457–465.
14. Cattanach BM, Kirk M (1985) Differential activity of maternally and paternally
derived chromosome regions in mice. Nature 315: 496–498.
15. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, et al. (1998) The
human GNAS1 gene is imprinted and encodes distinct paternally and
biallelically expressed G proteins. Proc Natl Acad Sci U S A 95: 10038–10043.
16. Kelsey G (2010) Imprinting on chromosome 20: tissue-specific imprinting and
imprinting mutations in the GNAS locus. Am J Med Genet C Semin Med Genet
154C: 377–386.
17. Peters J, Williamson CM (2007) Control of imprinting at the Gnas cluster.
Epigenetics 2: 207–213.
18. Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, et al. (1999) A cluster of
oppositely imprinted transcripts at the Gnas locus in the distal imprinting region
of mouse chromosome 2. Proc Natl Acad Sci U S A 96: 3830–3835.
19. Plagge A, Kelsey G, Germain-Lee EL (2008) Physiological functions of the
imprinted Gnas locus and its protein variants Gas and XLas in human and
mouse. J Endocrinol 196: 193–214.
20. Weinstein LS, Xie T, Qasem A, Wang J, Chen M (2010) The role of GNAS and
other imprinted genes in the development of obesity. Int J Obes (Lond) 34: 6–17.
21. Kehlenbach RH, Matthey J, Huttner WB (1994) XLas is a new type of G
protein. Nature 372: 804–809.
22. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, et al. (2002)
Receptor-mediated adenylyl cyclase activation through XLas, the extra-large
variant of the stimulatory G protein a-subunit. Mol Endocrinol 16: 1912–1919.
23. Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, et al. (2009) Central nervous
system imprinting of the G protein Gsa and its role in metabolic regulation. Cell
Metab 9: 548–555.
24. Germain-Lee EL, Ding CL, Deng Z, Crane JL, Saji M, et al. (2002) Paternal
imprinting of Gas in the human thyroid as the basis of TSH resistance in
Pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 296:
67–72.
25. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, et al.
(2005) A mouse model of Albright Hereditary Osteodystrophy generated by
targeted disruption of exon 1 of the Gnas gene. Endocrinology 146: 4697–4709.
26. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, et al. (2001)
Imprinting of the Gsa gene GNAS1 in the pathogenesis of acromegaly. J Clin
Invest 107: R31–36.
27. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A (2002) The Gsa
gene: predominant maternal origin of transcription in human thyroid gland and
gonads. J Clin Endocrinol Metab 87: 4736–4740.
28. Coombes C, Arnaud P, Gordon E, Dean W, Coar EA, et al. (2003) Epigenetic
properties and identification of an imprint mark in the Nesp-Gnasxl domain of
the mouse Gnas imprinted locus. Mol Cell Biol 23: 5475–5488.
29. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB (2000)
Characterization of the extra-large G protein a-subunit XLas. I. Tissue
distribution and subcellular localization. J Biol Chem 275: 33622–33632.
30. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, et al. (2004) The imprinted
signaling protein XLas is required for postnatal adaptation to feeding. Nat
Genet 36: 818–826.
31. Liu J, Chen M, Deng C, Bourc’his D, Nealon JG, et al. (2005) Identification of
the control region for tissue-specific imprinting of the stimulatory G protein a-
subunit. Proc Natl Acad Sci U S A 102: 5513–5518.
32. Williamson CM, Ball ST, Nottingham WT, Skinner JA, Plagge A, et al. (2004) A
cis-acting control region is required exclusively for the tissue-specific imprinting
of Gnas. Nat Genet 36: 894–899.
33. Williamson CM, Turner MD, Ball ST, Nottingham WT, Glenister P, et al.
(2006) Identification of an imprinting control region affecting the expression of
all transcripts in the Gnas cluster. Nat Genet 38: 350–355.
34. Bastepe M, Frohlich LF, Linglart A, Abu-Zahra HS, Tojo K, et al. (2005)
Deletion of the NESP55 differentially methylated region causes loss of maternal
GNAS imprints and Pseudohypoparathyroidism type Ib. Nat Genet 37: 25–27.
35. Chotalia M, Smallwood SA, Ruf N, Dawson C, Lucifero D, et al. (2009)
Transcription is required for establishment of germline methylation marks at
imprinted genes. Genes Dev 23: 105–117.
36. Williamson CM, Ball ST, Dawson C, Mehta S, Beechey CV, et al. (2011)
Uncoupling antisense-mediated silencing and DNA methylation in the imprinted
Gnas cluster. PLoS Genet 7: e1001347.
37. Pasolli HA, Huttner WB (2001) Expression of the extra-large G protein a-
subunit XLas in neuroepithelial cells and young neurons during development of
the rat nervous system. Neurosci Lett 301: 119–122.
38. Liu Z, Segawa H, Aydin C, Reyes M, Erben RG, et al. (2011) Transgenic
overexpression of the extra-large Gsa variant XLas enhances Gsa-mediated
responses in the mouse renal proximal tubule in vivo. Endocrinology 152:
1222–1233.
39. Xie T, Plagge A, Gavrilova O, Pack S, Jou W, et al. (2006) The alternative
stimulatory G Protein a-subunit XLas is a critical regulator of energy and
glucose metabolism and sympathetic nerve activity in adult mice. J Biol Chem
281: 18989–18999.
40. Cattanach BM, Peters J, Ball S, Rasberry C (2000) Two imprinted gene
mutations: three phenotypes. Hum Mol Genet 9: 2263–2273.
41. Chen M, Gavrilova O, Liu J, Xie T, Deng C, et al. (2005) Alternative Gnas gene
products have opposite effects on glucose and lipid metabolism. Proc Natl Acad
Sci U S A 102: 7386–7391.
42. Kelly ML, Moir L, Jones L, Whitehill E, Anstee QM, et al. (2009) A missense
mutation in the non-neural G-protein a-subunit isoforms modulates suscepti-
bility to obesity. Int J Obes (Lond) 33: 507–518.
43. Skinner JA, Cattanach BM, Peters J (2002) The imprinted oedematous-small
mutation on mouse chromosome 2 identifies new roles for Gnas and Gnasxl in
development. Genomics 80: 373–375.
44. Klemke M, Kehlenbach RH, Huttner WB (2001) Two overlapping reading
frames in a single exon encode interacting proteins–a novel way of gene usage.
Embo J 20: 3849–3860.
45. Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, et al. (2000) High-
efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet
25: 139–140.
46. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, et al. (1999) Disruption of
the glucocorticoid receptor gene in the nervous system results in reduced
anxiety. Nat Genet 23: 99–103.
47. Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the
ubiquitous deletion of loxP-flanked gene segments including deletion in germ
cells. Nucleic Acids Res 23: 5080–5081.
48. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality. Cell 69: 915–926.
49. Dymecki SM (1996) A modular set of Flp, FRT and lacZ fusion vectors for
manipulating genes by site-specific recombination. Gene 171: 197–201.
50. Lee G, Saito I (1998) Role of nucleotide sequences of loxP spacer region in Cre-
mediated recombination. Gene 216: 55–65.
51. Dubois NC, Hofmann D, Kaloulis K, Bishop JM, Trumpp A (2006) Nestin-Cre
transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated
recombination in the nervous system, kidney, and somite-derived tissues. Genesis
44: 355–360.
52. Schnutgen F, Doerflinger N, Calleja C, Wendling O, Chambon P, et al. (2003) A
directional strategy for monitoring Cre-mediated recombination at the cellular
level in the mouse. Nat Biotechnol 21: 562–565.
53. Wang HL, Morales M (2009) Pedunculopontine and laterodorsal tegmental
nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic
neurons in the rat. Eur J Neurosci 29: 340–358.
54. Fay RA, Norgren R (1997) Identification of rat brainstem multisynaptic
connections to the oral motor nuclei in the rat using pseudorabies virus. II.
Facial muscle motor systems. Brain Res Brain Res Rev 25: 276–290.
55. Feldman JL, Neverova NV, Saywell SA (2005) Modulation of hypoglossal
motoneuron excitability by intracellular signal transduction cascades. Respir
Physiol Neurobiol 147: 131–143.
56. Lund JP, Kolta A, Westberg KG, Scott G (1998) Brainstem mechanisms
underlying feeding behaviors. Curr Opin Neurobiol 8: 718–724.
57. Martin E, Devidze N, Shelley D, Westberg L, Fontaine C, et al. (2011)
Molecular and neuroanatomical characterization of single neurons in the mouse
medullary gigantocellular reticular nucleus. J Comp Neurol 519: 2574–2593.
58. Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-
norepinephrine function: adaptive gain and optimal performance. Annu Rev
Neurosci 28: 403–450.
59. Kohlmeier KA, Kristiansen U (2010) GABAergic actions on cholinergic
laterodorsal tegmental neurons: implications for control of behavioral state.
Neuroscience 171: 812–829.
60. Martinez-Gonzalez C, Bolam JP, Mena-Segovia J (2011) Topographical
organization of the pedunculopontine nucleus. Front Neuroanat 5: 22.
61. Song CK, Vaughan CH, Keen-Rhinehart E, Harris RB, Richard D, et al. (2008)
Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to
brown adipose tissue: neuroanatomical and functional evidence. Am J Physiol
Regul Integr Comp Physiol 295: R417–428.
62. Chitravanshi VC, Bhatt S, Sapru HN (2009) Microinjections of a-melanocyte
stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated
bradycardia. Am J Physiol Regul Integr Comp Physiol 296: R1402–1411.
63. Bouret SG, Simerly RB (2004) Minireview: Leptin and development of
hypothalamic feeding circuits. Endocrinology 145: 2621–2626.
64. Grove KL, Grayson BE, Glavas MM, Xiao XQ, Smith MS (2005) Development
of metabolic systems. Physiol Behav 86: 646–660.
65. Coll AP, Farooqi IS, O’Rahilly S (2007) The hormonal control of food intake.
Cell 129: 251–262.
66. Grill HJ, Hayes MR (2009) The nucleus tractus solitarius: a portal for visceral
afferent signal processing, energy status assessment and integration of their
combined effects on food intake. Int J Obes (Lond) 33 Suppl 1: S11–15.
67. Fan W, Morrison SF, Cao WH, Yu P (2007) Thermogenesis activated by central
melanocortin signaling is dependent on neurons in the rostral raphe pallidus
(rRPa) area. Brain Res 1179: 61–69.
68. Oldfield BJ, Giles ME, Watson A, Anderson C, Colvill LM, et al. (2002) The
neurochemical characterisation of hypothalamic pathways projecting polysyn-
aptically to brown adipose tissue in the rat. Neuroscience 110: 515–526.
Postnatal Changes in XLas Expression Pattern
PLoS ONE | www.plosone.org 16 January 2012 | Volume 7 | Issue 1 | e2975369. Morrison SF, Nakamura K (2011) Central neural pathways for thermoregula-
tion. Front Biosci 16: 74–104.
70. Yoshida K, Li X, Cano G, Lazarus M, Saper CB (2009) Parallel preoptic
pathways for thermoregulation. J Neurosci 29: 11954–11964.
71. Zhang Y, Kerman IA, Laque A, Nguyen P, Faouzi M, et al. (2011) Leptin-
receptor-expressing neurons in the dorsomedial hypothalamus and median
preoptic area regulate sympathetic brown adipose tissue circuits. J Neurosci 31:
1873–1884.
72. Dimicco JA, Zaretsky DV (2007) The dorsomedial hypothalamus: a new player
in thermoregulation. Am J Physiol Regul Integr Comp Physiol 292: R47–63.
73. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, et al.
(2007) The central melanocortin system directly controls peripheral lipid
metabolism. J Clin Invest 117: 3475–3488.
74. Rossi J, Balthasar N, Olson D, Scott M, Berglund E, et al. (2011) Melanocortin-4
receptors expressed by cholinergic neurons regulate energy balance and glucose
homeostasis. Cell Metab 13: 195–204.
75. Skibicka KP, Grill HJ (2009) Hypothalamic and hindbrain melanocortin
receptors contribute to the feeding, thermogenic, and cardiovascular action of
melanocortins. Endocrinology 150: 5351–5361.
76. Voss-Andreae A, Murphy JG, Ellacott KL, Stuart RC, Nillni EA, et al. (2007)
Role of the central melanocortin circuitry in adaptive thermogenesis of brown
adipose tissue. Endocrinology 148: 1550–1560.
77. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD (2000) A metabolic
defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl
Acad Sci U S A 97: 12339–12344.
78. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE (2005) Melanocortin-4
receptor-deficient mice are not hypertensive or salt-sensitive despite obesity,
hyperinsulinemia and hyperleptinemia. Hypertension 46: 326–332.
79. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK (2009) Role of
central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab
20: 203–215.
80. Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and
leptin resistance. Am J Physiol Endocrinol Metab 297: E1247–1259.
81. Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, et al. (2009) Enhanced
orexin receptor-2 signaling prevents diet-induced obesity and improves leptin
sensitivity. Cell Metab 9: 64–76.
82. Cerri M, Morrison SF (2006) Corticotropin releasing factor increases in brown
adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus
and medullary raphe pallidus. Neuroscience 140: 711–721.
83. Phelps CJ (2004) Postnatal regression of hypothalamic dopaminergic neurons in
prolactin-deficient Snell dwarf mice. Endocrinology 145: 5656–5664.
84. Howell JJ, Manning BD (2011) mTOR couples cellular nutrient sensing to
organismal metabolic homeostasis. Trends Endocrinol Metab 22: 94–102.
85. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, et al. (2006)
Hypothalamic mTOR signaling regulates food intake. Science 312: 927–930.
86. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, et al. (2004) Absence of
S6K1 protects against age- and diet-induced obesity while enhancing insulin
sensitivity. Nature 431: 200–205.
87. Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, et al. (1994)
Independent regulatory elements in the nestin gene direct transgene expression
to neural stem cells or muscle precursors. Neuron 12: 11–24.
88. Pacilli A, Pasquinelli G (2009) Vascular wall resident progenitor cells: a review.
Exp Cell Res 315: 901–914.
89. Nogueiras R, Perez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, et al.
(2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor
signaling is mediated by the sympathetic nervous system and blunted in diet-
induced obesity. J Neurosci 29: 5916–5925.
90. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, et al. (2011) The
mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-
mediated inhibition of growth factor signaling. Science 332: 1317–1322.
91. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, et al. (2011)
Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that
negatively regulates insulin signaling. Science 332: 1322–1326.
92. Smith FM, Holt LJ, Garfield AS, Charalambous M, Koumanov F, et al. (2007)
Mice with a disruption of the imprinted Grb10 gene exhibit altered body
composition, glucose homeostasis, and insulin signaling during postnatal life.
Mol Cell Biol 27: 5871–5886.
93. Ren J, Lee S, Pagliardini S, Gerard M, Stewart CL, et al. (2003) Absence of
Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in
congenital deficiency of central respiratory drive in neonatal mice. J Neurosci 23:
1569–1573.
94. Schaller F, Watrin F, Sturny R, Massacrier A, Szepetowski P, et al. (2010) A
single postnatal injection of oxytocin rescues the lethal feeding behaviour in
mouse newborns deficient for the imprinted Magel2 gene. Hum Mol Genet 19:
4895–4905.
95. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, et al. (2010)
The Angelman Syndrome protein Ube3A regulates synapse development by
ubiquitinating Arc. Cell 140: 704–716.
96. Gregg C, Zhang J, Weissbourd B, Luo S, Schroth GP, et al. (2010) High-
resolution analysis of parent-of-origin allelic expression in the mouse brain.
Science 329: 643–648.
97. Ugur O, Jones TL (2000) A proline-rich region and nearby cysteine residues
target XLas to the Golgi complex region. Mol Biol Cell 11: 1421–1432.
Postnatal Changes in XLas Expression Pattern
PLoS ONE | www.plosone.org 17 January 2012 | Volume 7 | Issue 1 | e29753